Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Clarke

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Clinical Radiology|July 1, 1973
A comparison of conventional and double contrast barium enemasJ R Young, J Stabler, W M Hazeldine, et al.
Anaesthesia|May 6, 2009
Evaluation of the LMA Supreme in 100 non-paralysed patientsT M Cook, J J Gatward, J Handel, et al.
Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.
Lancet (London, England)|April 19, 1997
BCL-2 antisense therapy in patients with non-Hodgkin lymphomaA Webb, D Cunningham, F Cotter, et al.
The British Journal of Surgery|December 1, 1994
Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancerP S Rooney, L M Hunt, P A Clarke, et al.
British Journal of Cancer|August 22, 2002
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequenceS A Watson, T M Morris, D F McWilliams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphomaJ S Waters, A Webb, D Cunningham, et al.
Oncogene|August 30, 2000
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneP A Clarke, I Hostein, U Banerji, et al.
British Journal of Cancer|December 4, 1998
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancyS L Parsons, S A Watson, H M Collins, et al.
Oncogene|December 3, 2013
Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteinsJ R Smith, E de Billy, S Hobbs, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Clinical Radiology|July 1, 1973
A comparison of conventional and double contrast barium enemasJ R Young, J Stabler, W M Hazeldine, et al.
Anaesthesia|May 6, 2009
Evaluation of the LMA Supreme in 100 non-paralysed patientsT M Cook, J J Gatward, J Handel, et al.
Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.
Lancet (London, England)|April 19, 1997
BCL-2 antisense therapy in patients with non-Hodgkin lymphomaA Webb, D Cunningham, F Cotter, et al.
The British Journal of Surgery|December 1, 1994
Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancerP S Rooney, L M Hunt, P A Clarke, et al.
British Journal of Cancer|August 22, 2002
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequenceS A Watson, T M Morris, D F McWilliams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphomaJ S Waters, A Webb, D Cunningham, et al.
Oncogene|August 30, 2000
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneP A Clarke, I Hostein, U Banerji, et al.
British Journal of Cancer|December 4, 1998
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancyS L Parsons, S A Watson, H M Collins, et al.
Oncogene|December 3, 2013
Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteinsJ R Smith, E de Billy, S Hobbs, et al.
Pageof 6